Research progress of screening for sarcopenia and frailty in the elderly
Received:December 29, 2018  
View Full Text  View/Add Comment  Download reader
DOI:10.11915/j.issn.1671-5403.2019.05.078
Key words:sarcopenia  frailty  screening This work was supported by the Health Care Scientific Research Project of Beijing
Author NameAffiliationE-mail
HOU Wen-Wen Department of Internal Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China  
CHANG Jing Department of Internal Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China  
SUN Qian-Mei Department of Internal Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China sunqianmei5825@126.com 
Hits: 1383
Download times: 1394
Abstract:
      Sarcopenia and frailty are common geriatric clinical syndromes, commonly lead to falls, incapacity and death, and thus, affect the quality of life in the elderly. Therefore, sufficient attention should be paid to screening for sarcopenia and frailty. There are many screening methods for both of them at home and abroad, but there is still no unified golden standard. In recent years, with in-depth research, some new methods have been proposed for the screening of sarcopenia and frailty. This paper reviewed the research status and advancement of screening and evaluation methods for sarcopenia and frailty in order to discover and identify the 2 diseases early in clinical practice.
Close